Literature DB >> 1425076

Hyperammoniemic coma in a patient with ureterosigmoidostomy and normal liver function.

J L Van Laethem1, F Gay, N Franck, A Van Gossum.   

Abstract

Hyperammoniemic encephalopathy has been reported after ureterosigmoidostomy. Its development is related to a problem of bacterial overgrowth and, most often, is favored by the presence of an underlying liver dysfunction. We report the case of a 43-year-old woman with a ureterosigmoidostomy done 28 years earlier who developed hyperammoniemic coma induced by an acute rectocolitis and in the absence of any detectable liver dysfunction. Neither administration of Lactilol and neomycin nor rectal tube drainage were effective; systemic antimicrobial therapy effective against the urease-producing gram-negative bacilli was required and led to a decrease in serum ammonia levels and a dramatic clinical improvement.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1425076     DOI: 10.1007/bf01299870

Source DB:  PubMed          Journal:  Dig Dis Sci        ISSN: 0163-2116            Impact factor:   3.199


  8 in total

1.  Ammonia intoxication following ureterosigmoidostomy in a patient with liver disease.

Authors:  R SILBERMAN
Journal:  Lancet       Date:  1958-11-01       Impact factor: 79.321

Review 2.  Hepatic encephalopathy: current status.

Authors:  S Schenker; K J Breen; A M Hoyumpa
Journal:  Gastroenterology       Date:  1974-01       Impact factor: 22.682

3.  Ammonia-induced coma after ureterosigmoidostomy.

Authors:  E Mortensen; G Lyng; E Juhl
Journal:  Lancet       Date:  1972-02-26       Impact factor: 79.321

4.  Recurrent hepatic coma following ureterosigmoidostomy.

Authors:  J Egense; M Schwartz
Journal:  Scand J Gastroenterol Suppl       Date:  1970

5.  Hyperammonemic encephalopathy caused by infection in a neurogenic bladder.

Authors:  C J Drayna; C P Titcomb; R R Varma; K H Soergel
Journal:  N Engl J Med       Date:  1981-03-26       Impact factor: 91.245

6.  Hyperammonemic encephalopathy related to ureterosigmoidostomy.

Authors:  R H Edwards
Journal:  Arch Neurol       Date:  1984-11

7.  Cerebral dysfunction in asymptomatic carriers of ornithine transcarbamylase deficiency.

Authors:  M L Batshaw; Y Roan; A L Jung; L A Rosenberg; S W Brusilow
Journal:  N Engl J Med       Date:  1980-02-28       Impact factor: 91.245

8.  [14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis.

Authors:  D A Henry; G Kitchingman; M J Langman
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

  8 in total
  4 in total

Review 1.  The neurology of enteric disease.

Authors:  A J Wills; D S N A Pengiran Tengah; G K T Holmes
Journal:  J Neurol Neurosurg Psychiatry       Date:  2006-03-30       Impact factor: 10.154

2.  Rapidly cycling encephalopathy from an almost forgotten entity.

Authors:  Lucio Tremolizzo; Alessio Galbussera; Maura Frigo; Paolo Apale; Maurizio Capra; Ildebrando Appollonio; Carlo Ferrarese
Journal:  Neurol Sci       Date:  2008-05-16       Impact factor: 3.307

Review 3.  Endogenous ornithine in search for CNS functions and therapeutic applications.

Authors:  N Seiler; G Daune-Anglard
Journal:  Metab Brain Dis       Date:  1993-09       Impact factor: 3.584

4.  Hyperammonemic encephalopathy in a patient with ureterosigmoidostomy and acute hepatitis: a specific case of fulminant hepatic failure.

Authors:  Shunsuke Ohnishi; Takeshi Yoshida; Hiroaki Makiyama; Katsuya Usui; Mayumi Kudo; Takahiko Kobayashi; Shuhei Hige; Masahiro Asaka
Journal:  Dig Dis Sci       Date:  2003-04       Impact factor: 3.199

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.